Cargando…

Die neue Parkinson-Schmerzklassifikation (PSK)

BACKGROUND: Chronic pain is a common non-motor symptom in patients with Parkinson’s disease (PD). AIM: To facilitate the diagnosis of pain in PD, we developed a new classification system the Parkinson’s disease pain classification system (PD-PCS) and translated the corresponding validated questionna...

Descripción completa

Detalles Bibliográficos
Autores principales: Mylius, V., Perez Lloret, S., Brook, C. S., Krüger, M. T., Hägele-Link, S., Gonzenbach, R., Kassubek, J., Bohlhalter, S., Lefaucheur, J. P., Timmermann, L., Kägi, G., Brugger, F., Ciampi de Andrade, D., Möller, J. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534980/
https://www.ncbi.nlm.nih.gov/pubmed/35089366
http://dx.doi.org/10.1007/s00115-021-01258-y
Descripción
Sumario:BACKGROUND: Chronic pain is a common non-motor symptom in patients with Parkinson’s disease (PD). AIM: To facilitate the diagnosis of pain in PD, we developed a new classification system the Parkinson’s disease pain classification system (PD-PCS) and translated the corresponding validated questionnaire into German. METHODS: A causal relationship of the respective pain syndrome with PD can be determined by four questions before assigning it hierarchically into one of three pain categories (neuropathic, nociceptive and nociplastic). RESULTS: In the initial validation study 77% of the patients (122/159) had PD-associated pain comprising 87 (55%) with nociceptive, 36 (22%) with nociplastic and 24 (16%) with neuropathic pain. The study revealed a high validity of the questionnaire and a moderate intrarater and interrater reliability. The questionnaire has been adapted into German and employed in 30 patients. DISCUSSION: The PD-PCS questionnaire is a valid and reliable tool to determine the relationship of a pain syndrome with PD before classifying it according to the underlying category, facilitating further diagnostics and treatment.